Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee | Johnson & Johnson

Vote based on totality of scientific evidence provided by the Company including safety and efficacy data

Read the full article here

Related Articles